Streptozocin

Generic name: Streptozocin
Brand names: Zanosar
Dosage form: intravenous powder for injection (1 g)
Drug class: Alkylating agents

Usage of Streptozocin

Streptozocin is used to treat pancreatic cancer.

Streptozocin may also be used for purposes not listed in this medication guide.

Streptozocin side effects

Get emergency medical help if you have signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.

Streptozocin may cause serious side effects. Call your doctor at once if you have:

little or no urinating, swelling, rapid weight gain;

confusion, loss of appetite, vomiting, pain in your side or lower back;

easy bruising, unusual bleeding, purple or red spots under your skin;

liver problems--stomach pain (upper right side), tiredness, itching, dark urine, clay-colored stools, jaundice (yellowing of the skin or eyes); or

low white blood cell counts--fever, mouth sores, skin sores, sore throat, cough, trouble breathing.

Common side effects of streptozocin may include:

nausea, vomiting; or

swelling, redness, burning, or tenderness where the medicine was injected.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Before taking Streptozocin

Tell your doctor if you have ever had:

kidney disease;

liver disease;

a bleeding or blood clotting disorder; or

bone marrow suppression.

Using streptozocin may increase your risk of developing other types of cancer, such as stomach cancer. Ask your doctor about your specific risk.

Streptozocin may harm an unborn baby. Use effective birth control to prevent pregnancy, and tell your doctor if you become pregnant.

You should not breastfeed while using streptozocin.

Relate drugs

How to use Streptozocin

Usual Adult Dose for Pancreatic Cancer:

This drug can be given on a daily or weekly basis.DAILY SCHEDULE:-Recommended Dose: 500 mg/m2 BSA IV by rapid injection or short/prolonged infusion once a day for 5 consecutive days every 6 weeks.-Dose escalation is not recommended.-Duration of Therapy: Until maximum benefit or until treatment-limiting toxicity occurs.WEEKLY SCHEDULE:-Initial Dose: 1000 mg/m2 BSA IV by rapid injection or short/prolonged infusion at weekly intervals for first 2 courses.-Maintenance Dose: After the first 2 courses, doses may be escalated in patients who have not achieved a therapeutic response and who have not experienced significant toxicity with the previous treatment course.-Maximum Dose: Single dose of 1500 mg/m2 BSAComments: -The ideal duration of maintenance therapy for both dosing schedules has not been established.-Therapy should be limited to patients with symptomatic or progressive metastatic disease due to the inherent renal toxicity of this drug.Use: Treatment of metastatic islet cell carcinoma of the pancreas

Warnings

Streptozocin can harm your liver or kidneys, and may also cause severe vomiting or diarrhea.

While receiving streptozocin, you should be able to get to a hospital or emergency room quickly in case you have a serious side effect. You may need frequent blood tests to make sure streptozocin is not causing harmful effects.

What other drugs will affect Streptozocin

Tell your doctor about all your other medicines, especially:

doxorubicin.

This list is not complete. Other drugs may affect streptozocin, including prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible drug interactions are listed here.

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.